miR-122 – A key factor and therapeutic target in liver diseaseSimonetta Bandiera(Inserm), Mirjam B. Zeisel(University Hospital of Zurich)Journal of HepatologyDecember 1, 201410.1016/j.jhep.2014.10.004Cited by 622SaveCiteExport RISWatch citationsRelated PapersTowards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure|Gut|2015|273Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81|Hepatology|2007|244